Matti Laato

4.4k total citations
107 papers, 3.5k citations indexed

About

Matti Laato is a scholar working on Surgery, Rehabilitation and Oncology. According to data from OpenAlex, Matti Laato has authored 107 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 24 papers in Rehabilitation and 20 papers in Oncology. Recurrent topics in Matti Laato's work include Wound Healing and Treatments (24 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Surgical Sutures and Adhesives (14 papers). Matti Laato is often cited by papers focused on Wound Healing and Treatments (24 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Surgical Sutures and Adhesives (14 papers). Matti Laato collaborates with scholars based in Finland, Sweden and Canada. Matti Laato's co-authors include Jyrki Kössi, J Niinikoski, Yrjö Collan, Juha Peltonen, Peter J. Boström, Hannu Paajanen, Marja Hilska, Martti Nurmi, Jyrki Heino and Klaus Elenius and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Matti Laato

105 papers receiving 3.4k citations

Peers

Countries citing papers authored by Matti Laato

Since Specialization

Citations

This map shows the geographic impact of Matti Laato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Laato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Laato more than expected).

Fields of papers citing papers by Matti Laato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Laato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Laato. The network helps show where Matti Laato may publish in the future.

Co-authorship network of co-authors of Matti Laato

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Laato. A scholar is included among the top collaborators of Matti Laato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Laato. Matti Laato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy 2016 ·Bladder Cancer ·Peter J. Boström, Tuomas Mirtti, Bas van Rhijn, Neil Fleshner, Antonio Finelli, Matti Laato, Michael A.S. Jewett, Malcom J. Moore, Srikala S. Sridhar, Martti Nurmi, Ian F. Tannock, Alexandre R. Zlotta	6
2	Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy 2016 ·Bladder Cancer ·Peter J. Boström, John Thoms, Jenna Sykes, (unknown), A. Evans, Bas W.G. van Rhijn, Tuomas Mirtti, (unknown), Matti Laato, David Margel, Melania Pintilie, Cynthia Kuk, Michael Milosevic, Alexandre R. Zlotta, Robert G. Bristow	30
3	Lack of Decorin Expression by Human Bladder Cancer Cells Offers New Tools in the Therapy of Urothelial Malignancies 2013 ·PLoS ONE ·Annele Sainio, Marie Nyman, Riikka Lund, (unknown), Pia Boström, Matti Laato, Peter J. Boström, Hannu Järveläinen	28
4	Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome 2012 ·British Journal of Urology ·Polat Türker, Peter J. Boström, Marcelo Langer Wroclawski, Bas van Rhijn, (unknown), Cynthia Kuk, Tuomas Mirtti, Neil Fleshner, Michael A.S. Jewett, Antonio Finelli, (unknown), (unknown), Joan Sweet, Matti Laato, Alexandre R. Zlotta	86
5	Virtsarakon katetrointi ja kystostooman laitto 2009 ·Matti Laato, Esa Kähkönen, Antti Rannikko, Peter J. Boström	0
6	Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept 2009 ·British Journal of Urology ·Jarmo K. Laihia, Liisa Pylkkänen, Matti Laato, Peter J. Boström, Lasse Leino	10
7	PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma 2009 ·Annals of Oncology ·Abdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, Jukka Laine, Yrjö Collan, Matti Laato, Karí Syrjänen, Seppo Pyrhönen	30
8	Prognostic significance of matrix metalloproteinases‐1, ‐2, ‐7 and ‐13 and tissue inhibitors of metalloproteinases‐1, ‐2, ‐3 and ‐4 in colorectal cancer 2007 ·International Journal of Cancer ·Marja Hilska, Peter Roberts‎, Yrjö Collan, V. Laine, Jyrki Kössi, Pirkko Hirsimäki, Otto Rahkonen, Matti Laato	128
9	Laparoscopic Sigmoid and Rectal Resection Using an Electrothermal Bipolar Vessel Sealing Device 2007 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Jyrki Kössi, Markku Luostarinen, (unknown), Matti Laato	16
10	The influence of training level and surgical experience on survival in colorectal cancer 2004 ·Langenbeck s Archives of Surgery ·Marja Hilska, Peter Roberts‎, (unknown), Hannu Paajanen, (unknown), Matti Laato	9
11	Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. 2003 ·PubMed ·Teemu T. Junttila, Matti Laato, Tero Vahlberg, Karl‐Ove Söderström, Tapio Visakorpi, Jorma Isola, Klaus Elenius	92
12	New Function for NF1 Tumor Suppressor 2000 ·Journal of Investigative Dermatology ·Jussi Koivunen, Heli Ylä‐Outinen, (unknown), Seija-Liisa Karvonen, Minna Pöyhönen, Matti Laato, Jaakko Karvonen, Sirkku Peltonen, Juha Peltonen	29
13	Upregulation of Tumor Suppressor Protein Neurofibromin in Normal Human Wound Healing and In Vitro Evidence for Platelet Derived Growth Factor (PDGF) and Transforming Growth Factor-β1 (TGF-β1) Elicited Increase in Neurofibromin mRNA Steady-State Levels in Dermal Fibroblasts 1998 ·Journal of Investigative Dermatology ·Heli Ylä‐Outinen, Vesa Aaltonen, (unknown), Outi Hirvonen, Jouni Lakkakorpi, (unknown), Matti Laato, Juha Peltonen	39
14	Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels 1998 ·Apmis ·Jorma Toppari, Antti Kaipia, Marko Kaleva, Matti Laato, David de Kretser, Lynne Krummen, Jennie P. Mather, Toivo T. Salmi	30
15	Tumor necrosis factor-α inhibits collagen synthesis in human and rat granulation tissue fibroblasts 1996 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), Jyrki Heino, Eero Vuorio, Matti Laato	32
16	Effects of Heterodimeric Isoform of Platelet-Derived Growth Factor PDGF-AB on Wound Healing in the Rat 1994 ·European Surgical Research ·(unknown), Harry Kujari, J Niinikoski, Matti Laato	18
17	Inflammatory Reaction and Blood Flow in Experimental Wounds Inoculated with <i>Staphylococcus aureus</i> 1988 ·European Surgical Research ·Matti Laato, J Niinikoski, Claes Lundberg, Bengt Gerdin	48
18	The effect of epidermal growth factor on granulation tissue formation in the rat. 1988 ·PubMed ·Matti Laato, (unknown)	12
19	Effect of a Hexosylceramide Fraction of the Hemodialysate Solcoseryl on Experimental Granulation Tissue 1986 ·European Surgical Research ·J Niinikoski, S Renvall, Matti Laato, (unknown), (unknown)	3
20	Effects of Extreme Haemodilution on the Immediate Post-Operative Course of Coronary Artery Bypass Patients 1983 ·European Surgical Research ·J Niinikoski, Matti Laato, V. Laaksonen, O. A. Meretoja, (unknown), M Arstila, M. V. Inberg	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact